Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001193125-26-051323·Gilde Healthcare Holding B.V.
Schedule 13D ownership disclosure
SpyGlass Pharma, Inc.
Common Stock, par value $0.00001 per share · CUSIP: 85220G109
Event date: 2026-02-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Gilde Healthcare Holding B.V.Reported CIK 0001420106
Shares: 2,187,513 · Class: 6.57%
- Gilde Healthcare VG VI Management B.V.
Shares: 2,187,513 · Class: 6.57%
- Cooperatieve Gilde Healthcare VG VI U.A.
Shares: 2,187,513 · Class: 6.57%
- Manapouri B.V.
Shares: 2,187,513 · Class: 6.57%
- Martemanshurk B.V.
Shares: 2,187,513 · Class: 6.57%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-051323
- Form type
- SCHEDULE 13D
- Filer
- Gilde Healthcare Holding B.V.
- CIK
- CIK 1420106
- Filed
- Feb 13, 2026
- Reporting period
- Feb 09, 2026
- Description
- Schedule 13D beneficial ownership